The Novel Structural Motif Gln
Gln
in the Integrin 
Cytoplasmic Domain Regulates Cell Proliferation (*)
- § To whom correspondence should be addressed: Dept. of Pathology, Yale University School of Medicine, P. O. Box 208023, 310 Cedar St., New Haven, CT 06520. Tel.: 203-737-1454; languino{at}biomed.med.yale.edu.
Abstract
Alternative splicing of the integrin β
subunit mRNA generates a variant form, β
, with a unique cytoplasmic domain that differs from β
for a 48-amino acid COOH-terminal sequence. The potential role of this unique sequence in modulating cellular functions was
investigated using Chinese hamster ovary (CHO)
cells transiently transfected with cDNAs coding for human integrin β
or β
subunits or mutants containing truncated forms of the β
cytoplasmic domain. A differential effect of β
and β
on cell proliferation was observed. Expression of wild type β
was associated with a 6-10-fold increase in cell proliferation in response to serum, as measured by [
H]thymidine incorporation. In contrast, only a 2-fold increase in cell proliferation was observed in transfectants expressing
comparable levels of β
. Cells expressing the β
mutant truncated at Leu
and lacking the last 31 amino acids of the cytoplasmic domain showed a 12-fold proliferation increase in response to serum.
However, three β
deletion mutants, lacking the COOH-terminal 23, 13, and 8 amino acids, which all contained residues Gln
-Gln
of the variant cytoplasmic domain responded to serum stimulation with a 2-fold increase in [
H]thymidine uptake. The effect of β
expression on cell proliferation was not associated with changes in exposure of integrin functional epitopes, as judged by
the finding that CHO transfectants expressing β
, full-length or deletion mutants, or β
equally adhered to a functionally inhibitory monoclonal antibody against human β
integrin. Expression of β
inversely correlated with the mitogenic potential of vascular cells. Absent on growing cultured endothelial cells, surface
expression of β
was induced in growth-arrested, tumor necrosis factor-stimulated endothelial cells. These findings suggest that integrin
alternative splicing may provide an accessory mechanism to modulate cell type-specific growth regulatory pathways during vascular
cell injury in vivo.
Footnotes
-
↵* This work was supported in part by American Cancer Society Grant IRG-IN 31-36 (to L. R. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
1 The abbreviations used are:
- CHO
-
Chinese hamster ovary
- HUVEC
-
human umbilical vein endothelial cell(s)
- DMEM
-
Dulbecco's modified Eagle's medium
- FCS
-
fetal calf serum
- TNF
-
tumor necrosis factor
- nt
-
nucleotide(s)
- FACS
-
fluorescence-activated cell sorting
- PAGE
-
polyacrylamide gel electrophoresis.
-
2M. Fornaro, G. Tallini, and L. R. Languino, unpublished observations.
-
- Received July 5, 1995.
- Revision received August 8, 1995.
- © 1995 by The American Society for Biochemistry and Molecular Biology, Inc.











